SRTA — Strata Critical Medical Share Price
Last trade - 00:00- $331.68m
- $218.26m
- $248.69m
- 76
- 59
- 45
- 63
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.49 | ||
| Price to Tang. Book | 2.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.55% | ||
| Return on Equity | -8.39% | ||
| Operating Margin | -9.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 23.43 | 50.53 | 146.12 | 225.18 | 248.69 | 263.17 | 281.97 | 51.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Strata Critical Medical, Inc., formerly Blade Air Mobility, Inc., provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, expanding its portfolio of services through acquisition and organic growth. The Company focuses on the contractual and macro-non-correlated marketplaces for organ logistics and other medical services. Its subsidiary, Trinity Medical Solutions (Trinity), is engaged in the air and ground transportation of human organs for transplant, leveraging its asset-light platform to deliver logistics solutions to its customers across the United States. Trinity provides a comprehensive, one call solution, which meets all transportation and logistics needs, including high-level logistics and transportation services for all air and ground mission requests, hand-carry/on-board courier movements, and next flight out services.
Directors
- Eric Affeldt CHM (63)
- Melissa Tomkiel PRE (41)
- Robert Wiesenthal CEO (54)
- William Heyburn CFO (32)
- Brandon Keene CTO (35)
- Amir Cohen CAO (45)
- Jane Garvey IND (77)
- Kenneth Lerer IND (64)
- Reginald Love IND
- Susan Lyne IND (71)
- Edward Philip IND (56)
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- May 24th, 2019
- Public Since
- September 17th, 2019
- No. of Shareholders
- 28
- No. of Employees
- 310
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 81,695,605
- Address
- 31 Hudson Yards, 14Th Floor, NEW YORK, 10001
- Web
- https://stratacritical.com/
- Phone
- +1 2129671009
- Contact
- Mathew Schneider
- Auditors
- Deloitte & Touche LLP
Similar to SRTA
36Kr Holdings
NASDAQ Capital Market
3 E Network Technology
NASDAQ Capital Market
A2Z Cust2mate Solutions
NASDAQ Capital Market
Abits
NASDAQ Capital Market
Acorn Energy
NASDAQ Capital Market
FAQ
As of Today at 23:26 UTC, shares in Strata Critical Medical are trading at $4.06. This share price information is delayed by 15 minutes.
Shares in Strata Critical Medical last closed at $4.06 and the price had moved by +39.52% over the past 365 days. In terms of relative price strength the Strata Critical Medical share price has outperformed the S&P500 Index by +16.42% over the past year.
The overall consensus recommendation for Strata Critical Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreStrata Critical Medical does not currently pay a dividend.
Strata Critical Medical does not currently pay a dividend.
Strata Critical Medical does not currently pay a dividend.
To buy shares in Strata Critical Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.06, shares in Strata Critical Medical had a market capitalisation of $331.68m.
Here are the trading details for Strata Critical Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SRTA
Based on an overall assessment of its quality, value and momentum Strata Critical Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Strata Critical Medical is $7.75. That is 90.89% above the last closing price of $4.06.
Analysts covering Strata Critical Medical currently have a consensus Earnings Per Share (EPS) forecast of -$0.13 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Strata Critical Medical. Over the past six months, its share price has outperformed the S&P500 Index by +12.72%.
As of the last closing price of $4.06, shares in Strata Critical Medical were trading +9.45% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Strata Critical Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Strata Critical Medical's management team is headed by:
- Eric Affeldt - CHM
- Melissa Tomkiel - PRE
- Robert Wiesenthal - CEO
- William Heyburn - CFO
- Brandon Keene - CTO
- Amir Cohen - CAO
- Jane Garvey - IND
- Kenneth Lerer - IND
- Reginald Love - IND
- Susan Lyne - IND
- Edward Philip - IND